![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 28, 2014 10:30:19 AM
Proprietary Name: Emesyl Nausea Relief
Non-Proprietary Name: Ipecacuanha, Tabacum, Zingiber officinale
Product Type Name: HUMAN OTC DRUG
Market Category Name : UNAPPROVED HOMEOPATHIC
Application Number:
Route Name: NASAL
Substance Name: GINGER; IPECAC; TOBACCO LEAF
Package Description : 1 BOTTLE, SPRAY in 1 CARTON (59067-001-01) > 15 mL in 1 BOTTLE, SPRAY
Pharm Class: N/A
DEA: N/A
Labeler Name: Itonis, Inc.
Start date: 05-20-2014 / End date: N/A
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM